I am concerned because my mother lives in an assisted living facility and her primary care doctor uses the telehealth service ...

Novo Nordisk is expanding access to its GLP-1 drug Wegovy via telehealth, partnering with Hims and Hers, Ro, and LifeMD.

Novo is expanding its direct-to-consumer efforts around its obesity drug Wegovy, partnering with telehealth companies ...

Monitoring equipment patients use at home has shown specific improvements in the management of hypertension, congestive heart ...

Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic ...

According to Grand View Research, the telehealth market size in the US was ... large-scale penetration of connected home services, and high internet usage. In addition, the global adoption of ...

VermontBiz U.S. Senator Peter Welch (D-Vt.) today discussed his new bipartisan, bicameral legislation to expand coverage of ...

Drugmaker Novo Nordisk announced Tuesday that Wegovy will be available through telehealth providers. The providers -- Hims & ...

According to a study presented at the Pediatric Academic Societies (PAS) 2025 Meeting, held April 24–28 in Honolulu, children ...

Telehealth became mainstream during the pandemic, and some people would prefer to stay home than drive to a health professional. Healthcare is going digital, and telehealth stocks let investors ...

Novo Nordisk said that it will begin offering its popular weight loss drug Wegovy through telehealth companies Hims & Hers, Ro and LifeMD to expand patient access, now that the medication is no longer ...